New Trump health policy limits access to vaccines against COVID

The Trump administration announced on Tuesday that it would restrict the authorization of seasonal COVID-19 vaccines to older individuals and those at high risk, while further data is gathered on the general population. This move raises concerns about the availability of the vaccine for those seeking it in the upcoming fall.

Top officials at the Food and Drug Administration (FDA) have introduced new guidelines for accessing updated COVID vaccines. They plan to continue a streamlined process to provide vaccines to adults aged 65 and above, as well as young children and adults with specific high-risk health conditions.

The FDA’s new framework, detailed in the New England Journal of Medicine, calls for extensive and prolonged studies before modified vaccines can be approved for healthier individuals. The FDA’s chief vaccine official mentioned in the article and a subsequent webcast that over 100 million Americans could be eligible for what is termed a booster shot under the new directive.

Dr. Vinay Prasad characterized this new strategy as a “commitment” to vaccinating high-risk groups while awaiting more data on the vaccine’s effectiveness for healthier populations. The implications for individuals who may not fit into the specified categories but still desire a COVID-19 vaccine in the fall remain uncertain.

Preliminary data from the Centers for Disease Control and Prevention indicates that COVID-related causes led to over 47,000 deaths in the US last year, with the virus being the primary cause in two-thirds of cases and a contributing factor in the remaining instances. Among these fatalities were 231 children, with 134 cases directly attributed to the virus, figures comparable to annual pediatric flu-related deaths.

This new FDA strategy marks the latest in a series of recent actions under Health Secretary Robert F. Kennedy Jr., reflecting a close examination of COVID vaccines and raising significant questions about broader vaccine availability. The announcement precedes the first meeting of external experts on FDA vaccines in the second term of President Donald Trump’s administration.

The Associated Press’ Department of Health and Science is supported by the Science and Education Media Group of the Howard Hughes Medical Institute and the Robert Wood Johnson Foundation, with the AP maintaining full responsibility for all content.